DYN FY 2022 Earnings — Dyne Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

DYNDyne Therapeutics, Inc.

$3B

FY 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$171M

Net Income

-$168M

EPS (Diluted)

$-3.23

Cash Flow

Operating Cash Flow

-$154M

Free Cash Flow

-$157M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$306M

Total Liabilities

$54M

Stockholders' Equity

$252M

Cash & Equivalents

$172M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$171M	-$150M	-14.0%
Net Income	-$168M	-$149M	-12.6%